Back to Search
Start Over
COVID-19 and inhibitors of the renin–angiotensin–aldosterone system
- Source :
- Expert Review of Anti-Infective Therapy, article-version (VoR) Version of Record, Expert Review of Anti-infective Therapy
- Publication Year :
- 2020
- Publisher :
- Taylor & Francis, 2020.
-
Abstract
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), main cause of coronavirus disease 2019 (COVID-19), uses the aminopeptidase angiotensin-converting enzyme 2 (ACE2) for entry into the ho...
- Subjects :
- 0301 basic medicine
Microbiology (medical)
hypertension
Coronavirus disease 2019 (COVID-19)
viruses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
030106 microbiology
Angiotensin-Converting Enzyme Inhibitors
angiotensin-receptor blockers
Pharmacology
Aminopeptidase
Microbiology
Renin-Angiotensin System
03 medical and health sciences
Angiotensin Receptor Antagonists
0302 clinical medicine
Virology
Renin–angiotensin system
Medicine
Humans
030212 general & internal medicine
chemistry.chemical_classification
business.industry
SARS-CoV-2
virus diseases
COVID-19
Angiotensin-converting enzyme 2
Enzyme
Infectious Diseases
Editorial
chemistry
Angiotensin Receptor Blockers
business
Subjects
Details
- Language :
- English
- ISSN :
- 17448336 and 14787210
- Database :
- OpenAIRE
- Journal :
- Expert Review of Anti-Infective Therapy
- Accession number :
- edsair.doi.dedup.....a784c80561e527d9b875b982c7b4ab9a